LD Micro Main Event Archives - Page 76 of 88

WednesdayDec 07, 2016 2:30 pm

Akoustis Technologies (AKTS) Starts Presentation at LD Micro Main Event

Akoustis Technologies (OTC: AKTS) is a tech company that operates in the telecommunications and fiber optics sector. The company designs and manufactures various radio frequency (RF) filters enabling the RF front-end of mobile wireless devices such as smartphones and tablets. It focuses on manufacturing and commercializing its patent-pending Bulk ONE acoustic wave technology to address the frequency-selectivity requirements in mobile smartphones, enhancing the efficiency and signal quality of mobile wireless devices and enabling The Internet of Things. For more information, visit the company's website at www.akoustis.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and…

WednesdayDec 07, 2016 2:30 pm

VBI Vaccines (VBIV) Starts Presentation at LD Micro Main Event

VBI Vaccines (NASDAQ: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI's first marketed product is Sci-B-Vac™, a hepatitis B ("HBV") vaccine, which is approved for use in Israel and 14 other countries. The company's eVLP Platform technology allows for the development of enveloped ("e") virus-like particle ("VLP") vaccines that closely mimic the target virus to elicit a potent immune response. VBI is advancing a pipeline of eVLP vaccines, with lead programs in cytomegalovirus ("CMV") and glioblastoma multiforme ("GBM"). VBI is also advancing its LPV™ Thermostability Platform,…

WednesdayDec 07, 2016 2:00 pm

First Choice Healthcare Solutions (FCHS) Starts Presentation at LD Micro Main Event

First Choice Healthcare Solutions (OTC: FCHS) is engaged in the provision of healthcare services in the United States. The company's network of non-physician-owned medical centers offer musculoskeletal and rehabilitative care services specializing in orthopedics, spine surgery, neurology, interventional pain management, and ambulatory surgical care. It also provides ancillary and diagnostic services comprising magnetic resonance imaging, X-ray, durable medical equipment, and rehabilitative care, including physical therapy and occupational therapy. For more information, visit the company's website at www.myfchs.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a…

WednesdayDec 07, 2016 2:00 pm

NAPCO Security Technologies (NSSC) Starts Presentation at LD Micro Main Event

NAPCO Security Technologies (NASDAQ: NSSC) manufactures and sells security products and software worldwide. It offers access control systems, door security products, intrusion and fire alarm systems, and video surveillance systems for commercial, residential, institutional, industrial and governmental applications. The company's access control systems include various types of identification readers, control panels, PC-based computers, and electronically activated door-locking devices; as well as door locking devices such as microprocessor-based electronic door locks with push button, card readers and bio-metric operation, door alarms, mechanical door locks, and simple dead bolt locks. For more information, visit the company's website at www.napcosecurity.com. About NetworkNewsWire NetworkNewsWire…

WednesdayDec 07, 2016 2:00 pm

MassRoots (MSRT) Starts Presentation at LD Micro Main Event

MassRoots (OTC: MSRT) operates a technology platform for the cannabis community in the United States. The company's mobile network enables users to share cannabis content to connect with the legalization movement. Its network is accessible as a free mobile application through the iOS App Store and the Google Play marketplace. The company also operates MassRoots.com/shop, an e-commerce platform that allows visitors to order MassRoots T-shirts, jars, and stickers; and MassRoots for Business. For more information, visit the company's website at www.massroots.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social…

WednesdayDec 07, 2016 2:00 pm

Ritter Pharmaceuticals (RTTR) Starts Presentation at LD Micro Main Event

Ritter Pharmaceuticals (NASDAQ: RTTR) is a pharmaceutical company that develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. The company's RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. Its RP-G28 has been studied in a phase 2a clinical trial. For more information, visit the company's website at www.ritterpharmaceuticals.com. About NetworkNewsWire NetworkNewsWire…

WednesdayDec 07, 2016 2:00 pm

Xplore Technologies (XPLR) Starts Presentation at LD Micro Main Event

Xplore Technologies (NASDAQ: XPLR) develops, integrates and markets rugged mobile personal computer systems (PCs) in the United States, Canada and internationally. The company's products enable the extension of traditional computing systems to a range of field personnel, including energy pipeline inspectors, public safety personnel, warehouse workers, and pharmaceutical scientists. It offers a line of iX104 tablet PCs that are designed to operate in various work environments, such as extreme temperatures, constant vibrations, rain and blowing dirt and dusty conditions. For more information, visit the company's website at www.xploretech.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release…

WednesdayDec 07, 2016 1:30 pm

Tonix Pharmaceuticals Holding (TNXP) Starts Presentation at LD Micro Main Event

Tonix Pharmaceuticals Holding (NASDAQ: TNXP) is a clinical-stage pharmaceutical company that develops medicines for common disorders of the central nervous system. The company's lead program focuses on post-traumatic stress disorder (PTSD) that is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet; a phase III clinical stage for the treatment of PTSD; and phase II clinical stage for the treatment of military-related PTSD. For more information, visit the company's website at www.tonixpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced…

WednesdayDec 07, 2016 1:30 pm

22nd Century Group (XXII) Starts Presentation at LD Micro Main Event

22nd Century Group (NYSE: XXII) is a plant biotech company providing technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. The company develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. For more information, visit the company's website at www.xxiicentury.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news…

WednesdayDec 07, 2016 1:30 pm

Heat Biologics (HTBX) Starts Presentation at LD Micro Main Event

Heat Biologics (NASDAQ: HTBX) is an immuno-oncology company developing novel therapies designed to activate a patient's immune system against cancer utilizing an engineered form of gp96, a protein that activates the immune system when cells die. Heat's highly specific T cell-stimulating therapeutic vaccine platform technologies, ImPACT and ComPACT, form the basis of its product candidates. Currently, Heat is conducting a phase 2 trial with its HS-410 in patients with non-muscle invasive bladder cancer (NMIBC) and a phase 1b trial with its HS-110 in combination with an anti-PD-1 checkpoint inhibitor to treat patients with non-small cell lung cancer (NSCLC). For more…